Tumor infiltrating CD8+ T lymphocytes are considered as an independent prognostic factor associated with improved patient survival in basal-like breast cancers, but not in non-basal triple-negative breast cancers, nor in other intrinsic molecular subtypes (26). The gene discussed is CD8A; the disease is breast carcinoma.